Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
87.33
+0.40 (0.46%)
Apr 21, 2026, 10:33 AM EDT - Market open
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $7.13 billion as of April 21, 2026. Its market cap has increased by 316.48% in one year.
Market Cap
7.13B
Enterprise Value
5.56B
1-Year Change
316.48%
Ranking
Category
Stock Price
$87.33
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $7.13B, an increase of 754.40%. That is a compound annual growth rate of 46.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 7.16B | 15.04% |
| Dec 31, 2025 | 6.22B | 138.91% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytokinetics | 8.22B |
| Halozyme Therapeutics | 8.21B |
| Krystal Biotech | 8.07B |
| ImmunityBio | 7.95B |
| Apogee Therapeutics | 6.81B |
| Protagonist Therapeutics | 6.76B |
| Arcellx | 6.75B |
| Belite Bio | 6.51B |